The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China

[1]  A. Paudel,et al.  Clinical and epidemiological features of COVID-19 deaths in Nepal , 2020, New Microbes and New Infections.

[2]  O. Brady,et al.  Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil , 2020, Nature Human Behaviour.

[3]  C. Mohan,et al.  Epidemiology and transmission dynamics of COVID-19 in two Indian states , 2020, Science.

[4]  N. Jewell,et al.  Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study , 2020, BMJ.

[5]  N. Jewell,et al.  Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study , 2020, BMJ.

[6]  G. Nagaraju,et al.  Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients , 2020, Cytokine & Growth Factor Reviews.

[7]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[8]  B. Larsen.  Faculty Opinions recommendation of Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. , 2020 .

[9]  A. Chughtai,et al.  Application of a Risk Analysis Tool to Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) Outbreak in Saudi Arabia , 2020, Risk analysis : an official publication of the Society for Risk Analysis.

[10]  T. Jiang,et al.  The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China , 2020, Journal of Autoimmunity.

[11]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[12]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[13]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[14]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[15]  Wei Liu,et al.  Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China , 2020, medRxiv.

[16]  Yang Liu,et al.  Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[17]  Wenhao Zhou,et al.  Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. , 2020, Translational pediatrics.

[18]  David A. Schwartz,et al.  Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections , 2020, Viruses.

[19]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[20]  X. Li,et al.  The vasoprotective axes of the renin‐angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases , 2017, Pharmacological research.

[21]  A. Al-Osail,et al.  The history and epidemiology of Middle East respiratory syndrome corona virus , 2017, Multidisciplinary Respiratory Medicine.

[22]  P. T. Ten Eyck,et al.  Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection , 2017, The Journal of Immunology.

[23]  G. Wali,et al.  Impact of Middle East Respiratory Syndrome coronavirus (MERS‐CoV) on pregnancy and perinatal outcome , 2016, BMC Infectious Diseases.

[24]  O. Jahn,et al.  TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.

[25]  A. Chawla,et al.  Connecting type 1 and type 2 diabetes through innate immunity. , 2012, Cold Spring Harbor perspectives in medicine.

[26]  T. Ng,et al.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome , 2004, American Journal of Obstetrics and Gynecology.

[27]  中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.  The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .

[28]  Chuanhua Yu,et al.  COVID-19 analysis and forecast based on Exponential Smoothing Model in Hubei Province/ 公共卫生与预防医学 , 2020 .